益生菌
基因组编辑
生物技术
生物
风险分析(工程)
业务
基因
清脆的
遗传学
细菌
作者
Lixuan Wang,Jing Hu,Kun Li,Yuliang Zhao,Motao Zhu
出处
期刊:iScience
[Elsevier]
日期:2024-08-23
卷期号:27 (9): 110791-110791
标识
DOI:10.1016/j.isci.2024.110791
摘要
Probiotics typically refer to microorganisms that have been identified for their health benefits, and they are added to foods or supplements to promote the health of the host. A growing number of probiotic strains have been identified lately and developed into valuable regulatory pharmaceuticals for nutritional and medical applications. Gene editing technologies play a crucial role in addressing the need for safe and therapeutic probiotics in disease treatment. These technologies offer valuable assistance in comprehending the underlying mechanisms of probiotic bioactivity and in the development of advanced probiotics. This review aims to offer a comprehensive overview of gene editing technologies applied in the engineering of both traditional and next-generation probiotics. It further explores the potential for on-demand production of customized products derived from enhanced probiotics, with a particular emphasis on the future of gene editing in the development of live biotherapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI